Moderna Burns Cash, Suffers Fresh Vaccine Setback
Moderna Inc. (NASDAQ: MRNA ) on Friday reported a second-quarter loss of $1.97 per share, beating the consensus loss of $2.10 per share. The COVID-19 vaccine maker reported sales of $145 million, better than the Wall Street estimate of $102.998 million. Lower COVID vaccine sales in the U.S. and South America were offse